Conjunctivitis Treatment Market Outlook:
Conjunctivitis Treatment Market size was over USD 5.08 Billion in 2025 and is projected to reach USD 7.96 Billion by 2035, growing at around 4.6% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of conjunctivitis treatment is evaluated at USD 5.29 Billion.
The growth of the market can be attributed to the increasing prevalence of infectious conjunctivitis disease across the world, along with the development & advancements in drug delivery methods for conjunctivitis treatment. Furthermore, there has been a surge in the number of bacteria and viruses that can affect the conjunctiva, and it is anticipated to boost the growth of the global conjunctivitis treatment market. For instance, as per the observations, the occurrence of conjunctivitis infection in the last 10 years was recognized in more than 20% of participants across the world.
In addition to these, factors that are believed to fuel the market growth of conjunctivitis treatment include the rising development & advancements in drug delivery methods for conjunctivitis treatment, coupled with technological advancements in ophthalmology treatment. Moreover, a significant rise in healthcare expenditure is also predicted to present the potential for market expansion over the projected period. For instance, the healthcare expenditure of the U.S. in 2020 rose to 9.7% and reached USD 4.1 trillion i.e., USD 12,530 per individual. Additionally, an upsurge in novel drug formulations and rising awareness among people regarding eye diseases is another significant factor that is projected to fuel the market growth throughout the forecast period.
